BioSpace News Archive

Policy

Johnson & Johnson Unit Sues Former Sales Rep Over Defection to Zimmer Biomet

The lawsuit, filed in the U.S. District Court for Eastern Pennsylvania, alleges that Mario Schackelman jumped ship for Zimmer Biomet on Oct. 31 after a decade of selling for Synthes despite clauses in his contract barring him for working for a competitor for two years.

December 21, 2017

·

1 min read

FDA

FDA Approves New Type 2 Diabetes Drug From Merck, Pfizer

The FDA approved Merck’s and Pfizer’s Steglatro, a SGLT2-inhibitor, that will square off against established drugs in the market.

December 21, 2017

·

2 min read

·

Alex Keown

3 Biotechs That Got Huge Boosts From Spark's FDA P

Drug Development

Kala Pharma’s Phase III Update is Just Around the Corner

Kala Pharma, is about to release some big news that will move this little company in a big way.

December 21, 2017

·

1 min read

Drug Development

Denali Therapeutics Announces Advancement and Expansion of Its LRRK2 Inhibitor Clinical Program for Parkinson’s Disease

Based on a full review of the clinical data from this ongoing study, and additional preclinical data, the FDA has removed the previously imposed partial clinical hold.

December 21, 2017

·

4 min read

Drug Development

Minerva Neurosciences Announces Enrollment of First Patient in Phase IIb Trial Comparing Seltorexant (MIN-202) Versus Quetiapine as Adjunctive Therapy to Antidepressants in Patients With Major Depressive Disorder

The primary objective of this study is to assess the efficacy of flexibly dosed seltorexant compared to flexibly dosed quetiapine as adjunctive therapy to a baseline antidepressant drug in delaying time to all-cause discontinuation of study drug over a 6-month treatment period.

December 21, 2017

·

4 min read

Biotech Bay

Advanced Bionics Sound Processors to Become Bluetooth Compatible With Any Cell Phone or TV, Based on Revolutionary New Chip Technology From Sonova

Advanced Bionics today announces that they will incorporate Sonova’s revolutionary SWORD (Sonova Wireless One Radio Digital) chip and wireless radio technology into their portfolio of solutions.

December 21, 2017

·

6 min read

Business

Summit Enters Into License and Commercialisation Agreement With Eurofarma for Latin American Rights to Ridinilazole, Summit’s Precision Antibiotic in Development for the Treatment of CDI

Summit announces that it has entered into an exclusive license and commercialisation agreement granting EuroPharma rights in Latin America to Summit’s precision antibiotic ridinilazole in development for the treatment of CDI.

December 21, 2017

·

9 min read

Business

CRISPR Therapeutics Announces Appointment of Dr. Rodger Novak as Chairman of the Board

Dr. Novak will succeed Dr. Tony Coles, who has helped lead the company in the transition from its early phase to a clinical-tage public company. Dr. Coles will remain a senior advisor to CRISPR Therapeutics.

December 21, 2017

·

5 min read

Biotech Bay

Catalyst Biosciences Announces Pricing of Public Offering of Common Stock

Catalyst Biosciences today announced the pricing of an underwritten public offering of 1,105,263 shares of its common stock, offered at a price of $9.50 per share to the public.

December 21, 2017

·

3 min read

Pharm Country

Integral Molecular Expands Its Epitope Mapping Platform to Identify Small Molecule Binding Sites on Multipass Membrane Proteins

Integral Molecular has now extended this mapping capability to small molecules, which comprise 50% of drugs in development.

December 21, 2017

·

2 min read